Lantern Pharma, Inc. (LTRN)
3.41
-0.07
(-2.01%)
USD |
NASDAQ |
Dec 29, 16:00
3.44
+0.03
(+0.88%)
After-Hours: 20:00
Lantern Pharma Market Cap: 38.14M for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 612.41M |
| Palatin Technologies, Inc. | 14.46M |
| Theriva Biologics, Inc. | 6.610M |
| Oragenics, Inc. | 0.6761M |
| NanoViricides, Inc. | 20.16M |
Market Cap Related Metrics
| Price to Book Value | 3.978 |
| Price | 3.41 |
| Earnings Yield | -51.40% |